Delegates from all parts of the clinical trial value chain come to Partnerships in Clinical Trials to quickly identify, engage and enter into strategic relationships that drive their clinical trials successfully forward as well as take part in the 60+ sessions and workshops geared to focus on several topic areas of interest, including risk-based monitoring, strategic sourcing, emerging market, patient adherence and more. This year’s Partnerships in Clinical Trials event is expected to draw upwards of 1,300 industry attendees for four days of high level networking, idea exchange and innovation.
Wednesday, April 22, 2015 @ 9:15am
The A-to-Z of RBM: Learn the key elements of risk management including terminology, definitions, principles and application in the clinical study area
Andy Lawton, Global Head of Data Management, Biometrics & Data Management, Boehringer Ingelheim
http://www.iirusa.com/cropartners/newagenda.xml?sessionId=2075
Wednesday, April 22, 2015 @ 2:00pm
Expert Panel: Collaborative Methodology for Risk-Based Monitoring of Clinical Trials: Practical Experience and Updates from TransCelerate Companies
Andy Lawton, Global Head of Data Management, Biometrics & Data Management, Boehringer Ingelheim
Mike Luker, Director, Clinical Research, Eli Lilly & Co.
Rebhar Tayyabkhan, Executive Director, Bristol-Myers Squibb
http://www.iirusa.com/cropartners/newagenda.xml?sessionId=2101
Thursday, April 23, 2015 @ 9:15am
Redefining Clinical Trials in the Age of Personalized Medicine
Ülo Palm, MD, PhD, MBA, SVP, Drug Development & Research Operations, Forest Laboratories
Isan Chen, MD, EVP, Chief Medical and Development Officer, Mirati Therapeutics
Erynn Gordon, Medical Marketing Director, 23&Me
Wendy Levin, MD, MS, Vice President, Clinical Development & Medical Affairs, MEI Pharma, Inc.
Niven Narain, Co-Founder, President & Chief Technology OfficerBerg Health
http://www.iirusa.com/cropartners/newagenda.xml?sessionId=2077
Thursday, April 23, 2015 @ 10:00am
Starting with a Blank Slate: how Would You Shape an Ideal Partnership
Andy Lee, Senior Vice President, Global Clinical Trial Operations, Merck
Murray Abramson, VP, Clinical Operations, Biogen Idec
Kenneth Getz, Director of Sponsored Programs, Tufts University School of Medicine
Paula Gildert, Head Development Strategic Sourcing DSS, Novartis Pharma AG
Harris Koffer, President of Strategic Solutions, PRA Health Sciences
John Oidtman, VP, Pfizer
Bernard Ravina, VP, Clinical Development, Voyager Therapeutics
http://www.iirusa.com/cropartners/newagenda.xml?sessionId=2078
Thursday, April 23, 2015 @ 11:15am
Show Me Your Data: How Transparency is Driving Drug Development
Andy Lawton, Global Head of Data Management, Biometrics & Data Management, Boehringer Ingelheim
Lynn Marks, MD, SVP Projects, Clinical Platforms & Science, GlaxoSmithKline
Peter Pitts, Former FDA Associate Commissioner for External Relations, President, Center for Medicine in the Public Interest
http://www.iirusa.com/cropartners/newagenda.xml?sessionId=2080
Friday, April 24. 2015 @ 9:45am
Update on TransCelerate Initiatives for 2015 + Beyond
Dalvir Gill, PhD – Chief Executive Officer at TransCelerate BioPharma Inc.
Andy Lee, SVP, Head of Global Clinical Trial Operations at Merck & Co
Reb Tayyabkhan, Head of Central Clinical Services at Bristol-Myers Squibb)
Craig Lipset – Head of Clinical Innovation at Pfizer
http://www.iirusa.com/cropartners/newagenda.xml?sessionId=2128
REGISTRATION: https://www.iirusa.com/cropartners/registration.xml?step=start